Autocrine transforming growth factor-β growth pathway in murine osteosarcoma cell lines associated with inability to affect phosphorylation of retinoblastoma protein

Sarcoma

Volumn 4, Issue 3, 2000, Pages 93-102

  Navid, Fariba ^a   Letterio, John J ^a   Yeung, Choh L ^a   Pegtel, Michiel ^a   Helman, Lee J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Osteosarcoma; Retinoblastoma protein; Smad proteins; Transforming growth factor

Indexed keywords

MESSENGER RNA; RETINOBLASTOMA PROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE ACTIVATION; GENE EXPRESSION REGULATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR GROWTH;

EID: 0033638672     PISSN: 1357714X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13577140020008057     Document Type: Article

References (61)

1. Transforming growth factor-β gene family members and bone
2. Effects of transforming growth factor-β on osteoblastic osteosarcoma cells
3. Effects of transforming growth factor β1 on the regulation of osteocalcin synthesis in human MG-63 osteosarcoma cells
4. Osteoblasts synthesize and respond to transforming growth factor-type β (TGFβ) in vitro
5. Growth-factor receptors and responses: A comparison of normal bone and osteosarcoma derived cell cultures
6. Expression of transforming growth factor-beta (TGF-β) receptors, TGF-β1 andTGF-β2 production and autocrine growth control in osteosarcoma cells
7. Relation between histological intensity of transforming growth factor-β isoforms in human osteosarcoma and the rate of lung metastasis
8. Expression of transforming growth factor β isoforms in osteosarcoma variants: Association of TGFβ1 with high-grade osteosarcomas
9. Expression of transforming growth factor-β (TGF-β) isoforms in osteosarcomas
10. Recombinant transforming growth factor type β3: Biological activities and receptor-binding properties in isolated bone cells
11. The transforming growth factor-β family
12. Receptors for the TGF-β family
13. Human transforming growth factor-β3: Recombinant expression, purification, and biological activities in comparison with transforming growth factors-β1 and -β2
14. Expression cloning and characterization of the TGF-β type III receptor
15. Betaglycan presents ligand to the TGF-β signaling receptor
16. TGFβ signals through a heteromeric protein kinase receptor complex
17. Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells
18. TGF-β receptor-mediated signalling through Smad2, Smad3, and Smad4
19. Identification of Smad2, a human Mad-related protein in the transforming growth factor b signaling pathway
20. Smads: Transcriptional activators of TGF-β responses
21. Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways
22. Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through Smad proteins
23. Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators
24. Transforming growth factor β and cell cycle regulation
25. TGFb inhibition of cdk4 synthesis is linked to cell cycle arrest
26. p15INK4B is a potential effector of TGF-β-induced cell cycle arrest
27. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β
28. p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
29. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation
30. Physical interaction of the retinoblastoma protein with human D cyclins
31. The retinoblastoma protein and cell cycle control
32. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
33. Somatic in vivo alterations of DPC4 gene at 18q21 in human lung cancer
34. Tumor suppressor activity of the TGF-β pathway in human cancers
35. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells
36. Expression of transforming growth factor b type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
37. Effects of transforming growth factor-β1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro
38. Transforming growth factor b stimulates mammary adenocarcinoma cell invasion and metastatic potential
39. Extracellular matrix-associated transforming growth factor-β: Role in cancer cell growth and invasion
40. Cyclosporine induces cancer progression by a cell-autonomous mechanism
41. Expression of a dominant-negative mutant TGF-β type II receptor in transgenic mice reveals essential role for TGF-β in regulation of growth and differentiation in the exocrine pancreas
42. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
43. Establishment and characterization of osteogenic cell lines from a spontaneous murine osteosarcoma
44. Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) in complex biological fluids
45. Transforming growth factor-β1: Histochemical localization with antibodies to different epitopes
46. Antibodies to transforming growth factor-β2 peptides: Specific detection of TGF-β2 in immunoassays
47. Localization and actions of transforming growth factor-βs in the embryonic nervous system
48. Rapid colorimetric assay for cell growth and survival
49. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II
50. The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor β1 in transgenic mice
51. TGFb-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein
52. Mutation spectrum of the retinoblastoma gene in osteosarcoma
53. Altered G1 phase regulation in osteosarcoma
54. Regulation of retinoblastoma protein functions by ectopic expresssion of human cyclins
55. Alterations of the p15, p16, and p18 genes in osteosarcoma
56. Transforming growth factor β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone
57. Transforming growth factor-beta modulates the expression of osteoblast and chondroblast phenotypes in vitro
58. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
59. DPC4 gene in various tumor types
60. Smad6 inhibits signalling by the TGF-β superfamily
61. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling